Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714814
Status:
UNKNOWN
Last Update Posted:
2021-03-23
First Post:
2021-01-12
Brief Title:
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
Sponsor:
Shanghai Minimally Invasive Surgery Center
Organization:
Shanghai Minimally Invasive Surgery Center
Study Overview
Official Title:
a Multi-omics Cohort Study of Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a two stage nested case-control study to construct the hologram plane explore biomarkers and screening original drugs of metastatic colorectal cancer
Detailed Description:
Stage Ⅰ is a cross-sectional study to record selected information and biospecimen of more than 200 colorectal cancer cases at least 160 stage Ⅲ cases40 stage Ⅳsynchronous metastasisStage Ⅱ is a nested case-control study 200 eligible cases enrolled in phaseⅠwill be followed up for 5 years to record recurrence metastasis and to collect biospecimen Each case with the study outcome will be matched with the corresponding control according to the proportion of 11 according to age sex and other conditions and further analysis will be made
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None